Symptomatic treatment in facioscapulohumeral dystrophy (FSHD): a case study

Magdalena Bitner-Bieleszuk

doi:10.5114/pm.2025.154562

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

3/2025
vol. 17

Send email

Copy url:

abstract:

Case report

Symptomatic treatment in facioscapulohumeral dystrophy (FSHD): a case study

Magdalena Bitner-Bieleszuk

¹

Clinical Department of Anaesthesiology and Intensive Therapy, Faculty of Medicine, Wroclaw Medical University, Poland

Medycyna Paliatywna 2025; 17(3): 179–183

DOI: https://doi.org/10.5114/pm.2025.154562

Online publish date: 2025/09/25

View full text Get citation

PlumX metrics:

Facioscapulohumeral dystrophy (FSHD) represents the third most prevalent form of muscular dystrophy observed in the adult population, exhibiting an overall incidence of over 1 in 10,000 individuals. Some studies suggest that up to 88.6% of patients with FSHD report pain. The most common sites of pain are the lumbosacral region, lower limbs, shoulders, and neck. The article aimed to present symptoms, diagnosis, and treatment options for FSHD based on latest publications, and a case study of a patient diagnosed with the disease admitted to the Pain Management and Palliative Care Center, University Hospital, Wroclaw. Based on described case study, it can be assumed that pain management requires multidisciplinary approach, combining different interventions, such as cannabis medicines, nerve blocks, and rehabilitation. However, further studies should be conducted among patients diagnosed with dystrophy, and guidelines need to be established.

keywords:

Symptomatic treatment in facioscapulohumeral dystrophy (FSHD): a case study

Magdalena Bitner-Bieleszuk 1

pain management, facioscapulohumeral muscular dystrophy, cannabinoids, neuromuscular diseases, interventional pain management

Magdalena Bitner-Bieleszuk

¹